Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Pharma-Bio Serv Inc. (PBSV : OTC)
 
 • Company Description   
Pharma-Bio Serv, Inc. provides consulting solutions to the pharmaceutical, chemical, medical device and biotechnology industries. Its services include regulatory compliance, validation, technology transfer, engineering, project management, process support, web pages, portals development, digital art design, intranets, extranets, software development, microbiological testing services, chemical testing services and technical trainings/seminars. The company operates in the U.S, Ireland and Spain. Pharma-Bio Serv, Inc. is headquartered in Dorado, Puerto Rico.

Number of Employees: 75

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.59 Daily Weekly Monthly
20 Day Moving Average: 3,331 shares
Shares Outstanding: 22.90 (millions)
Market Capitalization: $13.59 (millions)
Beta: 0.71
52 Week High: $0.70
52 Week Low: $0.35
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 9.85% 11.52%
12 Week 8.15% 4.46%
Year To Date -1.13% -1.00%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
PO Box 1049
-
DORADO,PR 00646
USA
ph: 787-278-2709
fax: 787-796-5168
scottg@corprominence.com http://www.pbsvinc.com
 
 • General Corporate Information   
Officers
Victor Sanchez - Chief Executive Officer and President
Kirk Michel - Chairman
Pedro J. Lasanta - Chief Financial Officer; Vice President Finance an
Howard Spindel - Director
Dov Perlysky - Director

Peer Information
Pharma-Bio Serv Inc. (CEB)
Pharma-Bio Serv Inc. (ACCL)
Pharma-Bio Serv Inc. (EFX)
Pharma-Bio Serv Inc. (NCI.)
Pharma-Bio Serv Inc. (TGISQ)
Pharma-Bio Serv Inc. (EXPO)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Consulting
Sector: Business Services
CUSIP: 71711N100
SIC: 8742
Fiscal Year
Fiscal Year End: October
Last Reported Quarter: 10/01/25
Next Expected EPS Date: 03/16/26
Share - Related Items
Shares Outstanding: 22.90
Most Recent Split Date: (:1)
Beta: 0.71
Market Capitalization: $13.59 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.03 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.11 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 03/16/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 5.39
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.14
Price/Cash Flow: -
Price / Sales: 1.51
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 100.00%
Sales Growth
vs. Year Ago Period: -7.84%
vs. Previous Quarter: 9.53%
ROE
01/31/26 - -
10/31/25 - -0.83
07/31/25 - -0.68
ROA
01/31/26 - -
10/31/25 - -0.70
07/31/25 - -0.56
Current Ratio
01/31/26 - -
10/31/25 - 7.70
07/31/25 - 7.93
Quick Ratio
01/31/26 - -
10/31/25 - 7.70
07/31/25 - 7.93
Operating Margin
01/31/26 - -
10/31/25 - -1.11
07/31/25 - -0.91
Net Margin
01/31/26 - -
10/31/25 - -1.11
07/31/25 - -0.91
Pre-Tax Margin
01/31/26 - -
10/31/25 - -1.05
07/31/25 - -1.23
Book Value
01/31/26 - -
10/31/25 - 0.52
07/31/25 - 0.52
Inventory Turnover
01/31/26 - -
10/31/25 - -
07/31/25 - -
Debt-to-Equity
01/31/26 - -
10/31/25 - 0.00
07/31/25 - 0.00
Debt-to-Capital
01/31/26 - -
10/31/25 - 0.00
07/31/25 - 0.00
 

Powered by Zacks Investment Research ©